GLP-1 medications may lower risk of acute pancreatitisGlucagon-like peptide-1 (GLP-1) receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those...
ESE expands journal portfolio with the launch of Environmental Endocrinology and Obesity and Endocrinology2 days ago
Qatar’s Ministry of Public Health launches Certification for Physicians in Obesity Management and Bariatric Care2 days ago